Posts Tagged ‘SLC45A3-ELK4 gene fusion’

A simple urine test may be all that’s needed to detect prostate cancer, if new findings in gene fusion research are validated.

A newly discovered gene fusion is highly expressed in a subset of prostate cancers, according to a study by researchers at Weill Cornell Medical College in the US.

The findings, reported in the April 1 issue of Cancer Research, may lead to more accurate tests for prostate cancer.

The gene fusion biomarker is also a different type of fusion than researchers have found in cancer previously and may represent an entirely new mechanism that cancer cells use to outgrow their healthy neighbors.

The SLC45A3-ELK4 gene fusion is detectable at high levels in the urine of some men at risk for prostate cancer. READ MORE>

Read Full Post »